Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 1364

Amended Proposed Jury Verdict by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Huston, Julia)

Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Doc. 1364

Case 1:05-cv-12237-WGY

Document 1364

Filed 10/12/2007

Page 1 of 5

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS AMGEN INC., Plaintiff, v. F. HOFFMANN-LA ROCHE LTD ROCHE DIAGNOSTICS GmbH and HOFFMANN-LA ROCHE INC. Defendants. ) ) ) ) ) ) ) CIVIL ACTION No.: 05-CV-12237WGY ) ) ) ) ) )

[DEFENDANTS' AMENDED PROPOSED] JURY VERDICT Defendants respectfully submit this Amended Proposed Verdict Form. Note for Court: Roche respectfully submits this Amended Jury Verdict Form to account for rulings made by the Court to date and the evidence adduced at trial. Roche reserves the right to further amend its Proposed Jury Verdict Form based on further rulings by the Court and further evidence.

755075_1

Dockets.Justia.com

Case 1:05-cv-12237-WGY

Document 1364

Filed 10/12/2007

Page 2 of 5

1. Considering each claim separately, has Roche demonstrated by clear and convincing evidence that each of the following claims is invalid? (Please place a check mark "Ö" in the box that reflects your verdict. A check mark in the "Yes" column is an answer for Roche, and a check mark in the "No" column is an answer for Amgen.) VALIDITY Invalid (Roche) U.S. Patent No. 5,955,422 Claim 1 U.S. Patent No. 5,441,868 Claim 1 Claim 2 U.S. Patent No. 5,618,698 Claim 6 Claim 7 Claim 8 Claim 9 U.S. Patent No. 5,756,349 Claim 7 U.S. Patent No. 5,547,933 Claim 3 Claim 7 Claim 8 Claim 9 Claim 11 Claim 12 Claim 14 Valid (Amgen)

2

Case 1:05-cv-12237-WGY

Document 1364

Filed 10/12/2007

Page 3 of 5

2.a. Considering each claim separately, has Amgen demonstrated by a preponderance of the evidence that Roche's MIRCERA® product infringes each element of the following claims? (Please place a check mark "Ö" in the box that reflects your verdict. A check mark in the "No" column is an answer for Roche, and a check mark in the "Yes" column is an answer for Amgen.) 2.b. If you find no literal infringement for any claim of the `933 patent, only then should you go on to answer this question for that claim in the column for Infringement by "Doctrine of Equivalents." (Please place a check mark "Ö" in the box that reflects your verdict. A check mark in the "No" column is an answer for Roche, and a check mark in the "Yes" column is an answer for Amgen.)

Literal Infringement No (Roche) U.S. Patent No. 5,547,933 Claim 3 Claim 7 Claim 8 Claim 9 Claim 12 U.S. Patent No. 5,441,868 Claim 1 Claim 2 U.S. Patent No. 5,618,698 Claim 6 Claim 7 Claim 8 Claim 9 U.S. Patent No. 5,756,349 Claim 7 Yes (Amgen)

Doctrine of Equivalents No (Roche) Yes (Amgen)

3

Case 1:05-cv-12237-WGY

Document 1364

Filed 10/12/2007

Page 4 of 5

3. Did Roche demonstrate by clear and convincing evidence that the patents-in-suit are unenforceable because Amgen engaged in inequitable conduct before the US Patent and Trademark Office? (Please place a check mark "Ö" in the box that reflects your verdict. A check mark in the "Yes" column is an answer for Roche, and a check mark in the "No" column is an answer for Amgen.) _____ Yes _____ No

______________________________ Foreperson Date ___________________

4

Case 1:05-cv-12237-WGY

Document 1364

Filed 10/12/2007

Page 5 of 5

Dated: October 12, 2007 Boston, Massachusetts

/s/ Julia Huston Lee Carl Bromberg (BBO# 058480) Julia Huston (BBO# 562160) Keith E. Toms (BBO# 663369) Nicole A. Rizzo (BBO# 663853) Kimberly J. Seluga (BBO# 667655) Emily J. Schaffer (BBO# 653752) BROMBERG & SUNSTEIN LLP 125 Summer Street Boston, MA 02110 Tel. [phone] [e-mail] Leora Ben-Ami (pro hac vice) Mark S. Popofsky (pro hac vice) Patricia A. Carson (pro hac vice) Thomas F. Fleming (pro hac vice) Howard S. Suh (pro hac vice) Peter Fratangelo (BBO# 639775) KAYE SCHOLER LLP 425 Park Avenue New York, NY 10022 Tel: [phone] CERTIFICATE OF SERVICE

I hereby certify that this document filed through the ECF system will be sent electronically to the registered participants as identified on the Notice of Electronic Filing (NEF). Pursuant to agreement of counsel dated September 9, 2007, paper copies will not be sent to those indicated as non registered participants. /s/ Julia Huston Julia Huston
03099/00501 755075.1

5